Method of treatment using new leurosine derivatives
US4279915A · kind A · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 1976 |
| Grant date | Jul 21, 1981 |
| Priority date | — |
| Expiry date | Nov 17, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
N-formylleurosine or a pharmaceutically effective salt is used in human therapy for treatment of lymphoma, leukemia or Hodgkins Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.